Hepion Pharmaceuticals, Inc.
HEPA
$0.2975
$0.01294.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 406.40K | 1.50M | 2.12M | 13.11M | 14.79M |
| Total Receivables | -- | 600.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.21M | 1.43M | 3.37M | 2.32M | 2.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.61M | 3.53M | 5.48M | 15.43M | 17.49M |
|
|
|||||
| Total Current Assets | 1.61M | 3.53M | 5.48M | 15.43M | 17.49M |
| Net Property, Plant & Equipment | 0.00 | 118.30K | 150.70K | 182.00K | 242.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 66.50K | 377.00K | 377.00K | 364.20K |
| Total Assets | 1.61M | 3.72M | 6.01M | 15.99M | 18.09M |
|
|
|||||
| Total Accounts Payable | 220.20K | 186.30K | 446.50K | 1.50M | 2.35M |
| Total Accrued Expenses | 23.70K | 306.00K | 375.00K | 793.80K | 1.74M |
| Short-term Debt | 2.90M | 2.11M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 118.00K | 154.10K | 134.00K | 115.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 149.00K | 1.09M |
| Total Other Current Liabilities | -- | -- | -- | 149.00K | 1.09M |
| Total Current Liabilities | 3.14M | 2.72M | 975.60K | 2.57M | 5.29M |
|
|
|||||
| Total Current Liabilities | 3.14M | 2.72M | 975.60K | 2.57M | 5.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.90M | 2.11M | -- | -- | -- |
| Capital Leases | -- | -- | -- | 41.20K | 93.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 333.20K | 1.41M | 1.47M | 5.85M | 5.43M |
| Total Liabilities | 3.48M | 4.12M | 2.45M | 8.47M | 10.81M |
|
|
|||||
| Common Stock & APIC | 234.25M | 234.22M | 233.33M | 233.30M | 230.29M |
| Retained Earnings | -237.82M | -236.27M | -231.41M | -227.48M | -224.63M |
| Treasury Stock & Other | 8.30K | -53.80K | -53.80K | 9.20K | -78.80K |
| Total Common Equity | -3.56M | -2.10M | 1.87M | 5.83M | 5.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
|
|
|||||
| Total Common Equity | -3.56M | -2.10M | 1.87M | 5.83M | 5.59M |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.86M | -406.70K | 3.56M | 7.52M | 7.28M |
|
|
|||||